Avista Healthcare Partners has taken control of Bentech Medical, a Woodland, California‑based specialist in silicone medical device components. The deal, announced by partner Rob Girardi, adds a niche manufacturer to Avista’s portfolio. CEO JG Singh, who founded the company in 1994, will remain at the helm following the transition.

Greyrock and Hermitage Equity Partners, the sellers, exited without public disclosure of financial terms. The transaction underscores Avista’s focus on high‑margin, specialty medical device makers. Bentech’s established supply chain and proprietary silicone molds position it well for growth in orthopedics and soft‑tissue applications.

Rob Girardi said the purchase offers Avista another compelling opportunity to invest in a highly attractive medical device manufacturing business. With Bentech’s niche expertise, Avista aims to deepen its footprint in the silicone component market, potentially unlocking synergies across its existing portfolio. The acquisition signals Avista’s continued commitment to specialty manufacturing growth.

The silicone medical device sector has seen steady demand as hospitals upgrade equipment and patients seek minimally invasive solutions. By adding Bentech, Avista gains access to a proven product line that supports implants, wound care devices, and diagnostic tools. This move could strengthen Avista’s bargaining power with suppliers and broaden revenue streams across the U.S. market.